Biophytis (EPA:ALBPS) | Finanzwire

Basculer en Français

9777	Companies
195695	Keywords
126733	Articles
104059	Press releases

Home
Companies
Biophytis

REGULATED PRESS RELEASE

published on 04/22/2025 at 07:00, 9 months 8 days ago

Biophytis targets mobility restoration in patients with obesity
Biophytis strengthens position in developing treatments for age-related muscle function loss in obesity care by focusing on quality weight loss and mobility restoration with BIO101 and GLP-1 therapies

Biophytis Muscle Function Obesity Care Quality Weight Loss Mobility Restoration
PRESS RELEASE

published on 04/22/2025 at 06:59, 9 months 8 days ago

Biophytis targets mobility restoration in patients with obesity
Biophytis focuses on preserving muscle function in obesity patients treated with GLP-1 therapies by developing BIO101. The aim is to improve quality of weight loss and mobility

Biophytis BIO101 Obesity Muscle Function GLP-1 Therapies
BRIEF

published on 04/09/2025 at 07:05, 9 months 21 days ago

Biophytis Initiates Phase 2 OBA Clinical Trial for Obesity Treatment

Biophytis Obesity Treatment Clinical Trial BIO101 Partnership Goal
REGULATED PRESS RELEASE

published on 04/09/2025 at 07:00, 9 months 21 days ago

Biophytis Confirms the Launch of the Phase 2 OBA Clinical Trial in Obesity
Biophytis confirms the Phase 2 OBA Clinical Trial launch in obesity, continuing development of BIO101 to reduce muscle strength loss. Seeking pharmaceutical partner for co-development

Biophytis BIO101 Obesity Pharmaceutical Partner Phase 2 OBA Clinical Trial
PRESS RELEASE

published on 04/09/2025 at 06:59, 9 months 21 days ago

Biophytis Confirms the Launch of the Phase 2 OBA Clinical Trial in Obesity
Biophytis confirms the launch of the Phase 2 OBA Clinical Trial in Obesity in 2025. The study aims to evaluate the efficacy of BIO101 in reducing muscle strength loss caused by GLP-1 agonists in obese patients

Biophytis BIO101 Obesity Muscle Strength Phase 2 OBA Clinical Trial
BRIEF

published on 03/28/2025 at 22:05, 10 months 2 days ago

Biophytis Finalizes €2.6 Million Private Placement

Private Placement Biophytis Warrants New Shares Euronext Growth
REGULATED PRESS RELEASE

published on 03/28/2025 at 22:00, 10 months 2 days ago

Biophytis announces the settlement and delivery of its €2.6 million private placement
Biophytis announces the settlement and delivery of its €2.6 million private placement. New shares admitted for trading on Euronext Growth. Maxim Group LLC and Invest Securities involved in the transaction

Private Placement Biophytis Euronext Growth Maxim Group LLC Settlement
PRESS RELEASE

published on 03/28/2025 at 21:59, 10 months 2 days ago

Biophytis announces the settlement and delivery of its €2.6 million private placement
Biophytis settles €2.6 million private placement, issuing new shares and warrants. Company specializes in age-related disease treatments

Private Placement Biophytis Warrants New Shares Age-related Diseases
BRIEF

published on 03/26/2025 at 07:40, 10 months 4 days ago

Biophytis Completes €2.6 Million Private Placement

Private Placement Biophytis Trading Capital Increase Clinical Programs
REGULATED PRESS RELEASE

published on 03/26/2025 at 07:35, 10 months 4 days ago

Biophytis announces the successful completion of a €2,6 million private placement
Biophytis successfully completes €2.6M private placement, aiming to accelerate clinical programs and partnerships, strengthen corporate purposes, and extend cash runway

Private Placement Biophytis Biotechnology Fundraising Clinical Programs

Accesswire

Published on 01/31/2026 at 00:00, 41 minutes ago

BE Resources Announces Private Placement
Published on 01/30/2026 at 23:00, 1 hour 41 minutes ago

Avidian Gold Corp. Announces Director Resignation
Published on 01/30/2026 at 22:45, 1 hour 56 minutes ago

Noram Lithium Announces Fully Allocated Non-Brokered Financing
Published on 01/30/2026 at 22:30, 2 hours 11 minutes ago

Alta Copper Receives Court Approval for Proposed Acquisition by Fortescue
Published on 01/30/2026 at 14:00, 10 hours 41 minutes ago

CCL to Hold Live Webcast to Discuss Fourth Quarter and Year End 2025 Results, Thursday, February 26, 2026, at 7:30 a.m. ET

View all ACCESSWIRE

EQS Group

Published on 01/30/2026 at 22:00, 2 hours 41 minutes ago

Nebius Group N.V. announces date of fourth quarter and full year 2025 results and conference call
Published on 01/30/2026 at 20:10, 4 hours 31 minutes ago

Cynosure Lutronic Announces Completion of EU MDR Approval and Global Momentum for Mosaic 3D™ Ahead of IMCAS 2026
Published on 01/30/2026 at 20:09, 4 hours 32 minutes ago

Aroundtown SA successfully issued AUD 600 million bonds in two tranches
Published on 01/30/2026 at 20:07, 4 hours 34 minutes ago

Aroundtown SA successfully issued AUD 600 million bonds in two tranches
Published on 01/30/2026 at 19:13, 5 hours 28 minutes ago

Total Voting Rights

Les Echos

Published on 01/30/2026 at 17:45, 6 hours 56 minutes ago

Schneider Electric launches a capital increase reserved for employees
Published on 01/30/2026 at 08:00, 16 hours 41 minutes ago

AMA: 4th Quarter & FY 2025 Revenues
Published on 01/29/2026 at 18:00, 1 day 6 hours ago

GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 1 day 6 hours ago

LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 1 day 6 hours ago

Cegedim generated LFL revenue growth of 1.1% in 2025

View all LES ECHOS COMFI WIRE